{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:36:21Z","timestamp":1769600181750,"version":"3.49.0"},"reference-count":34,"publisher":"Impact Journals, LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,1,26]]},"DOI":"10.18632\/oncotarget.6657","type":"journal-article","created":{"date-parts":[[2015,12,24]],"date-time":"2015-12-24T15:31:04Z","timestamp":1450971064000},"page":"3662-3676","source":"Crossref","is-referenced-by-count":23,"title":["A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells"],"prefix":"10.18632","volume":"7","author":[{"given":"Elizabeth M.","family":"Matthew","sequence":"first","affiliation":[{"name":"Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Division of Hematology-Oncology, Penn State Hershey Cancer Institute, Hershey, PA, USA"},{"name":"Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medical Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanlan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Division of Hematology-Oncology, Penn State Hershey Cancer Institute, Hershey, PA, USA"},{"name":"Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medical Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohai","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T.","family":"Dicker","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Division of Hematology-Oncology, Penn State Hershey Cancer Institute, Hershey, PA, USA"},{"name":"Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medical Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheldon L.","family":"Holder","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Penn State Milton S. Hershey Medical Center and Penn State Hershey Cancer Institute, Hershey, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bora","family":"Lim","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Division of Hematology-Oncology, Penn State Hershey Cancer Institute, Hershey, PA, USA"},{"name":"Division of Hematology-Oncology, Penn State Milton S. Hershey Medical Center and Penn State Hershey Cancer Institute, Hershey, PA, USA"},{"name":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramdane","family":"Harouaka","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Penn State University, University Park, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Yang","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Penn State University, University Park, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J.","family":"Drabick","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Penn State Milton S. Hershey Medical Center and Penn State Hershey Cancer Institute, Hershey, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas E.","family":"Lamparella","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Penn State Milton S. Hershey Medical Center and Penn State Hershey Cancer Institute, Hershey, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina I.","family":"Truica","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Penn State Milton S. Hershey Medical Center and Penn State Hershey Cancer Institute, Hershey, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wafik S.","family":"El-Deiry","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Division of Hematology-Oncology, Penn State Hershey Cancer Institute, Hershey, PA, USA"},{"name":"Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medical Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2015,12,18]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fonc.2012.00068","article-title":"Cornering metastases: therapeutic targeting of circulating tumor cells and stem cells","volume":"2","author":"Faltas","year":"2012","journal-title":"Front Oncol"},{"key":"2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-3-642-28160-0_18","article-title":"CTCs in metastatic breast cancer","volume":"195","author":"Cristofanilli","year":"2012","journal-title":"Recent Results Cancer Res"},{"key":"3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa040766","article-title":"Circulating tumor cells, disease progression, and survival in metastatic breast cancer","volume":"351","author":"Hayes","year":"2004","journal-title":"N Engl J Med"},{"key":"4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrc2375","article-title":"Detection, clinical relevance and specific biological properties of disseminating tumour cells","volume":"8","author":"Brandt","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/annonc\/mdn786","article-title":"Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer","volume":"20","author":"Meropol","year":"2009","journal-title":"Ann Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.urology.2004.11.006","article-title":"Circulating tumor cells predict survival in patients with metastatic prostate cancer","volume":"65","author":"Terstappen","year":"2005","journal-title":"Urology"},{"key":"7","first-page":"25ra23","article-title":"Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer","volume":"2","author":"Iafrate","year":"2010","journal-title":"Sci Transl Med"},{"key":"8","first-page":"179ra147","article-title":"Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells","volume":"5","author":"Walsh","year":"2013","journal-title":"Sci Transl Med"},{"key":"9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrclinonc.2011.158","article-title":"Carcinomas of an unknown primary origin\u2014diagnosis and treatment","volume":"8","author":"Fizazi","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrc2627","article-title":"Parallel progression of primary tumours and metastases","volume":"9","author":"Klein","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"11","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.2967\/jnumed.109.063925","article-title":"Multispectral fluorescence imaging","volume":"50","author":"El-Deiry","year":"2009","journal-title":"J Nucl Med"},{"key":"12","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/ncomms2635","article-title":"Quantum dot imaging platform for single-cell molecular profiling","volume":"4","author":"Gao","year":"2013","journal-title":"Nat Commun"},{"key":"13","first-page":"617421","article-title":"Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer","volume":"2010","author":"Terstappen","year":"2010","journal-title":"J Oncol"},{"key":"14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.gde.2010.10.010","article-title":"Utilizing circulating tumor cells: challenges and pitfalls","volume":"21","author":"de Bono","year":"2011","journal-title":"Curr Opin Genet Dev"},{"key":"15","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1158\/1078-0432.CCR-06-1695","article-title":"Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system","volume":"13","author":"Pantel","year":"2007","journal-title":"Clin Cancer Res"},{"key":"16","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.4161\/cc.25165","article-title":"Predicting therapy response in live tumor cells isolated with the flexible micro spring array device","volume":"12","author":"El-Deiry","year":"2013","journal-title":"Cell Cycle"},{"key":"17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1373\/clinchem.2013.206805","article-title":"Flexible micro spring array device for high-throughput enrichment of viable circulating tumor cells","volume":"60","author":"Zheng","year":"2014","journal-title":"Clin Chem"},{"key":"18","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/modpathol.3880175","article-title":"Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases","volume":"13","author":"Weiss","year":"2000","journal-title":"Mod Pathol"},{"key":"19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.semdp.2005.11.001","article-title":"Immunohistochemistry in diagnostic surgical pathology of the prostate","volume":"22","author":"Humphrey","year":"2005","journal-title":"Semin Diagn Pathol"},{"key":"20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1365-2559.2000.00801.x","article-title":"Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B","volume":"36","author":"Dietel","year":"2000","journal-title":"Histopathology"},{"key":"21","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/S0959-8049(03)00547-1","article-title":"Diagnostic and therapeutic management of cancer of an unknown primary","volume":"39","author":"Greco","year":"2003","journal-title":"Eur J Cancer"},{"key":"22","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1097\/PAS.0b013e3180536678","article-title":"The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate","volume":"31","author":"Illei","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"23","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0090-4295(84)90416-3","article-title":"Immunoperoxidase localization of prostatic antigens. Comparison of primary and metastatic sites","volume":"24","author":"Petersen","year":"1984","journal-title":"Urology"},{"key":"24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<171::AID-CNCR24>3.0.CO;2-V","article-title":"Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors","volume":"85","author":"Tot","year":"1999","journal-title":"Cancer"},{"key":"25","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1158\/1078-0432.CCR-04-2236","article-title":"Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm","volume":"11","author":"Oien","year":"2005","journal-title":"Clin Cancer Res"},{"key":"26","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Aus","year":"2009","journal-title":"N Engl J Med"},{"key":"27","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Parkin","year":"2010","journal-title":"Int J Cancer"},{"key":"28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1309\/G1RA-EU9X-X6VV-3W79","article-title":"Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma","volume":"113","author":"Rubin","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1309\/G6PR-Y774-X738-FG2K","article-title":"Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores","volume":"117","author":"Goldstein","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"30","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ygyno.2011.04.039","article-title":"Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients","volume":"122","author":"Fehm","year":"2011","journal-title":"Gynecol Oncol"},{"key":"31","doi-asserted-by":"crossref","first-page":"e75038","DOI":"10.1371\/journal.pone.0075038","article-title":"Heterogeneity of estrogen receptor expression in circulating tumor cells from metastatic breast cancer patients","volume":"8","author":"Joosse","year":"2013","journal-title":"PLoS One"},{"key":"32","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/j.1582-4934.2011.01285.x","article-title":"Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal","volume":"15","author":"Gazzaniga","year":"2011","journal-title":"J Cell Mol Med"},{"key":"33","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1158\/1541-7786.MCR-10-0490","article-title":"Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers","volume":"9","author":"Garcia-Blanco","year":"2011","journal-title":"Mol Cancer Res"},{"key":"34","first-page":"451","article-title":"Immunohistochemical demonstration of prostate-specific antigen in metastases with the use of monoclonal antibody F5","volume":"121","author":"Valenzuela","year":"1985","journal-title":"Am J Pathol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6657","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T17:18:53Z","timestamp":1589217533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,18]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,1,26]]}},"alternative-id":["6657","26695546"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.6657","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,18]]}}}